You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NK-cell

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis Trial in Poland (CPL409116, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • Bydgoszcz, Poland
  • +6 more
May 10, 2022

Extremes of Coronary Artery Disease and Normality:CAD Extremes

Not yet recruiting
  • Coronary Artery Disease
  • Blood draw
  • (no location specified)
Mar 7, 2023

Relapsed/Refractory Multiple Myeloma(MM) Trial in Guangdong (CART therapy in Relapsed/Refractory multiple myeloma)

Terminated
  • Relapsed/Refractory Multiple Myeloma(MM)
  • CART therapy in Relapsed/Refractory multiple myeloma
  • Guangdong, Guangdong, China
    Southern Medical University Zhujiang Hospital
Sep 17, 2021

Esophagus Squamous Cell Carcinoma Trial in Huai'an (raltitrexed)

Active, not recruiting
  • Esophagus Squamous Cell Carcinoma
  • Huai'an, Jiangsu, China
    Huai'an First Hospital
Apr 5, 2021

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Puerto Rico,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +8 more
  • Birmingham, Alabama
  • +859 more
Jul 19, 2021

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
Has Results
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Breast Cancer, Triple Negative Breast Cancer Trial in Houston, Sugar Land (Everolimus)

Completed
Has Results
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Houston, Texas
  • +2 more
Jul 16, 2021

Cytomegalovirus (CMV) Trial in United States (Maribavir)

Completed
Has Results
  • Cytomegalovirus (CMV)
  • Los Angeles, California
  • +31 more
May 12, 2021

Squamous Cell Carcinoma of the Anal Canal Trial in Worldwide (carboplatin, paclitaxel, retifanlimab)

Recruiting
  • Squamous Cell Carcinoma of the Anal Canal
  • Tucson, Arizona
  • +85 more
Jun 13, 2022

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Refractory High Risk Myelodysplastic Syndrome Trial in

Completed
  • Myelodysplastic Syndrome
  • +4 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 11, 2021

Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Montréal (Imvamune)

Recruiting
  • Non-melanoma Skin Cancer
  • +2 more
  • Imvamune
  • Montréal, Quebec, Canada
    McGill University Health Centre
Nov 26, 2020

Osteo Arthritis Knee Trial in La Jolla (Bone Marrow Aspirate Concentrate, Angel Concentrated Platelet Rich Plasma (cPRP) System)

Recruiting
  • Osteo Arthritis Knee
  • Bone Marrow Aspirate Concentrate
  • Angel Concentrated Platelet Rich Plasma (cPRP) System
  • La Jolla, California
    University of California San Diego Koman Outpatient Pavilion
Jan 24, 2022

Biology of Long-Term Late Effects Following Hematopoietic Cell

Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    Mar 8, 2022

    Acute Myeloid Leukemia, Adult Trial in Germany (Midostaurin)

    Terminated
    • Acute Myeloid Leukemia, Adult
    • Chemnitz, Germany
    • +3 more
    Jan 20, 2022

    Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in

    Not yet recruiting
    • Locally Advanced Pancreatic Adenocarcinoma
    • +6 more
    • Biopsy
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Apr 26, 2022

    Alzheimer's Disease Trial in San Diego, Cleveland (AAV2-BDNF Gene Therapy)

    Recruiting
    • Alzheimer's Disease
    • AAV2-BDNF Gene Therapy
    • San Diego, California
    • +1 more
    Sep 1, 2021

    Cytomegalovirus Infections Trial (Cytotect®CP)

    Recruiting
    • Cytomegalovirus Infections
    • Lille, France
      Hop Claude Huriez Chu Lille
    Nov 8, 2022

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Infusion of NEXI-001 T Cells
    • Duarte, California
    • +4 more
    Feb 16, 2021

    Wolfram Syndrome, Diabetes, Optic Nerve Atrophy Trial in Saint Louis (dantrolene sodium)

    Active, not recruiting
    • Wolfram Syndrome
    • +3 more
    • dantrolene sodium
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 16, 2022

    Letermovir Prophylaxis for CMV Infection in Haplo-HSCT

    Recruiting
    • CMV Infection
    • Hematopoietic Stem Cell Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Mar 29, 2023

    SARS-CoV-2 Infection Trial in Aix-en-Provence (nasal spray)

    Terminated
    • SARS-CoV-2 Infection
    • nasal spray
    • Aix-en-Provence, France
      Dr Bouvier's Office
    Nov 14, 2022

    Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer Trial in Nashville (drug, biological, other,

    Recruiting
    • Colorectal Cancer
    • +3 more
    • Glutaminase Inhibitor CB-839
    • +5 more
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Mar 29, 2022

    Non-Hodgkin's Lymphoma (NHL), Peripheral T Cell Lymphoma (PTCL) Trial in Tianjin (Ex-vivo expanded allogeneic ?dT cells)

    Recruiting
    • Non-Hodgkin's Lymphoma (NHL)
    • Peripheral T Cell Lymphoma (PTCL)
    • Ex-vivo expanded allogeneic γδT cells
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Disease Hospital
    Jan 5, 2021

    Relapsed/ Refractory Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, PD-1 Inhibitor)

    Recruiting
    • Relapsed/ Refractory Multiple Myeloma
    • Denver, Colorado
    • +19 more
    Jan 27, 2023

    Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

    Not yet recruiting
    • Lung Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 19, 2023